Abiopharma

Johnson & Johnson - Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

Marshall Robert J. Jr. 🔴 sold 727 shares of Lantheus Holdings, Inc. (LNTH) at $54.90 Transaction Date: Aug 29, 2025 | Filing ID: 015276

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Apfelbaum Sean Michael 🟢 acquired 200.0K shares (1 derivative) of Vireo Growth Inc. (VREOF) Transaction Date: Aug 31, 2025 | Filing ID: 087051

Duxbury Joseph 🟢 acquired 360.0K shares (1 derivative) of Vireo Growth Inc. (VREOF) Transaction Date: Aug 31, 2025 | Filing ID: 087050

New Form 8-K - CROSS COUNTRY HEALTHCARE INC Filed: 2025-09-03 AccNo: 0000950103-25-011190 Size: 203 KB Item 8.01: Other Events

Taylor Brenton 🟢 acquired 25.8K shares of Sight Sciences, Inc. (SGHT) Transaction Date: Sep 02, 2025 | Filing ID: 000006

RSLGH, LLC 🟢 acquired 43.1K shares (2 derivative) of RYTHM, Inc. (RYM) at $0.00 Transaction Date: Sep 01, 2025 | Filing ID: 084054

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-09-03 AccNo: 0001972481-25-000189 Size: 4 KB

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-09-03 AccNo: 0001972481-25-000188 Size: 5 KB

Petersen Floyd F. 🔴 sold 500 shares of Amphastar Pharmaceuticals, Inc. (AMPH) at $30.98 Transaction Date: Sep 02, 2025 | Filing ID: 023538

Stacherski Kenneth R. 🔴 sold 892 shares of GE HealthCare Technologies Inc. (GEHC) at $73.73 Transaction Date: Sep 01, 2025 | Filing ID: 000008

Le Grand Anne Bryce 🟢 acquired 78.9K shares (1 derivative) of ACCURAY INC (ARAY) Transaction Date: Aug 29, 2025 | Filing ID: 013291

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman